期刊文献+

HAART治疗前后HIV-1细胞嗜性分析 被引量:1

Analysis of HIV-1 cell tropism in patients receiving HAART
下载PDF
导出
摘要 目的分析7例患者在高效抗逆转录病毒治疗(HAART)前和治疗后,艾滋病病毒Ⅰ型(HIV-1)细胞嗜性的改变及影响因素。方法采用BD公司的流式细胞仪,通过绝对计数法测定CD4+T淋巴细胞计数和CD8+T淋巴细胞计数,荧光标记物为BD TriTEST CD3FITC/CD4PE/CD45PerCP。采用核酸序列扩增实验(NASBA)测定病毒载量(生物梅里埃公司提供仪器和试剂)。套式聚合酶链反应(Nested-PCR)对gp120V3环区基因进行扩增、测序分析,并确定HIV-1细胞嗜性。结果在7例患者中,有3例发生细胞嗜性转换,2例是从R5到X4嗜性的转换,1例是X4到R5嗜性的转换。在7例患者中,病毒细胞嗜性转换与患者病毒载量、CD4+、CD8+T淋巴细胞之间无相关性。结论HIV-1细胞嗜性的转换与疾病进展的关系不确定;HAART治疗对嗜性转换的作用还不明确。 Objective To analyze HIV-1 cell tropism in 7 AIDS patients before and after HAART and its related factors. Method Genome DNA was abstracted from patients' whole blood and HIV-1 Env gene was amplified using nested- PCR. Then the sequence was analyzed by CEXPRESS,BIOEIDT software. Coreceptor phenotype was predicted after sequencing the V3 loop of the HIV-1 glycoprotein 120 using biosoftware geno2pheno (Coreceptor on website-http:// www.geno2pheno.org). And HIV-1 cell tropism was finally determined. Result Among the 7 patients switch of HIV- 1 cell tropism was observed in 3 cases,of whom two switched from R5 to X4 and one switched from X4 to R5. The switch of cell tropism had no correlation with patients' viral loads, CD4^+ or CD8^+ T lymphocytes. Conclusion The relationship between the switch of HIV-1 cell tropism and the progress of AIDS is indefinite, and the effect of HAART on switch of tropism remains unknown.
出处 《中国艾滋病性病》 CAS 2008年第4期330-332,共3页 Chinese Journal of Aids & STD
基金 国家自然科学基金(No.30771906)
  • 相关文献

参考文献12

  • 1Pollakis G, Kang S, Kliphuis A, et al. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 eoreeeptorutilization [ J ]. J Biol Chem, 2001,20 ; 276(16) :13433 - 13441.
  • 2Witt A, Kaiser R, Mayer A, et al.HIV colonizing peripheral blood monocytes follow lymphocytic isolates in shifting from NSI to SI genotype[J]. Arch Virol, 1996,141(10) : 1833 - 1846.
  • 3Sing T, Beerenwinkel N, Lengauer T. Learning mixtures of localized rules by maximizing the area under the ROC curve[A]. Hern'andez- Orallo JFC, Lachiche N, Flach P, editors.Proceedings of the ROCAI -2004 international workshop on ROC analysis in artificial intelligence[ C]. 2004,89 - 96.
  • 4Sing T, Beerenwinkel N, Kaiser R, et al. Geno2pheno[coreceptor] : a tool for predcting coreceptor usage from genotype and for monitoring coreceptor-associated sequence alterations [ A] . Proceedings of the third European HIV drug resistance workshop[C]. 2005.
  • 5Fouchier RA, Brouwer M, Broersen SM, et al. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR [ J ]. J Clin Microbiol, 1995,33 : 906 - 911.
  • 6Pastore C, Ramos A, Mosier DE. Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching [J ] .J Virol, 2004, 78 (14) :7565 - 7574.
  • 7Shioda T, Levy J A, Cheng-Mayer C, et al. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T cell line and macrophage tropism of human immunodeficiency virus type 1 [J]. Proc Natl Acad Sci USA, 1992,89 : 9434 - 9438.
  • 8De Jong J J, De Ronde A, Keulen W, et al. Minimal requirement for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing ( SI ) phenotype [ J ] . J Virol, 1992,66:6777 - 6780.
  • 9Karlsson I, Grivel JC, Chen SS, et al. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue[J] .J Immunol, 2005, 175( 11 ) : 7586 - 7593.
  • 10Foda M,Harada S, Maeda Y.Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity [J]. Microbiol Immunol,2001,45(7) :521 - 530.

同被引文献14

  • 1康辉,王亚男,范霞,刁莹莹,代娣,尚红.淋巴细胞表面CCR5在HCV与HIV感染中表达[J].中国公共卫生,2006,22(4):421-422. 被引量:3
  • 2Wu Z,Liu Z,Detels R.HIV-1 infection in commercial plasma donors in China[J].Lancet,1995,346(8966):61-62.
  • 3Berger EA,Murphy PM,Farber JM.Chemokine receptors as HIV-1 coreceptors:roles in viral entry,tropism,and disease[J].Annu Rev Immunol,1999,17:657-700.
  • 4Schuitemaker H,van't Wout AB,Lusso P.Clinical significance of HIV-1 coreceptor usage[J].J Transl Med,2010,9(Suppl 1):S5.
  • 5Nattermann J,Nischalke HD,Feldmann G,et al.Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5[J].J Viral Hepat,2004,11(6):519-526.
  • 6Regoes RR,Bonhoeffer S.The HIV coreceptor switch:a population dynamical perspective[J].Trends Microbiol,2005,13(6):269-277.
  • 7Ghany MG,Strader DB,Thomas DL,et al.Diagnosis,management,and treatment of hepatitis C:an update[J].Hepatology,2009,49(4):1335-1374.
  • 8Tamura K,Peterson D,Peterson N,et al.MEGA5:molecular evolutionary genetics analysis using maximum likelihood,evolutionary distance,and maximum parsimony methods[J].Mol Biol Evol,2011,28(10):2731-2739.
  • 9Shang H,Zhong P,Liu J,et al.High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China[J].PLoS One,2010,5(5):e10631.
  • 10Zhang L,Chen Z,Cao Y,et al.Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China[J].J Virol,2004,78(24):13591-13599.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部